• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Liver Fibrosis and Atherosclerosis, a Consequence of Metabolic Dysfunction-Do They Share a Similar Pathophysiological Background?

作者信息

Muzurović Emir, Maćešić Marija, Kavarić Sreten

机构信息

Department of Internal Medicine, Endocrinology Section, Clinical Centre of Montenegro, Podgorica, Montenegro.

Faculty of Medicine, University of Montenegro, Podgorica, Montenegro.

出版信息

Angiology. 2025 Sep;76(8):717-719. doi: 10.1177/00033197241234076. Epub 2024 Feb 15.

DOI:10.1177/00033197241234076
PMID:38358750
Abstract
摘要

相似文献

1
Liver Fibrosis and Atherosclerosis, a Consequence of Metabolic Dysfunction-Do They Share a Similar Pathophysiological Background?肝纤维化与动脉粥样硬化——代谢功能障碍的后果，它们是否具有相似的病理生理背景？
Angiology. 2025 Sep;76(8):717-719. doi: 10.1177/00033197241234076. Epub 2024 Feb 15.
2
Nonalcoholic Fatty Liver非酒精性脂肪肝
3
The prevalence and correlates of advanced fibrosis in patients with and without diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.糖尿病患者与非糖尿病患者以及代谢功能障碍相关脂肪性肝病患者中晚期肝纤维化的患病率及其相关因素：一项横断面研究。
J Diabetes Complications. 2025 Aug 6;39(10):109147. doi: 10.1016/j.jdiacomp.2025.109147.
4
Comparison of the magnetic resonance elastography and FIB-4 (MEFIB) Index and vibration-controlled transient elastography for significant metabolic dysfunction-associated steatotic liver disease fibrosis.磁共振弹性成像与FIB-4（MEFIB）指数及振动控制瞬时弹性成像在显著代谢功能障碍相关脂肪性肝病肝纤维化中的比较
Can Liver J. 2024 Dec 19;7(4):419-426. doi: 10.3138/canlivj-2024-0007. eCollection 2024 Dec.
5
Healthy sleep patterns and risk of incident cardiovascular disease, liver-related events, and all-cause mortality among individuals with metabolic dysfunction--associated steatotic liver disease: A large prospective cohort study.代谢功能障碍相关脂肪性肝病患者的健康睡眠模式与心血管疾病、肝脏相关事件及全因死亡率的发生风险：一项大型前瞻性队列研究
Sleep Health. 2025 Aug 22. doi: 10.1016/j.sleh.2025.07.007.
6
Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis.代谢功能障碍相关脂肪性肝病与心房颤动：发病机制综述
World J Cardiol. 2025 Jun 26;17(6):106147. doi: 10.4330/wjc.v17.i6.106147.
7
Metabolic Dysfunction-Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population-Based Study.代谢功能障碍相关脂肪性肝病、饮酒与心房颤动风险：一项基于全国人口的研究
J Am Heart Assoc. 2025 Jul 15;14(14):e042003. doi: 10.1161/JAHA.125.042003. Epub 2025 Jul 14.
8
Metabolic dysfunction-associated steatotic liver disease: A story of muscle and mass.代谢功能障碍相关脂肪性肝病：肌肉与体重的故事。
World J Gastroenterol. 2025 May 28;31(20):105346. doi: 10.3748/wjg.v31.i20.105346.
9
The Significance of the Presence of Gilbert's Syndrome in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Retrospective Cohort Study.吉尔伯特综合征在代谢功能障碍相关脂肪性肝病（MASLD）患者中的意义：一项回顾性队列研究
Cureus. 2025 May 30;17(5):e85074. doi: 10.7759/cureus.85074. eCollection 2025 May.
10
Metabolic dysfunction-associated steatotic liver disease (MASLD). Assessing metabolic dysfunction, cardiovascular risk factors, and lifestyle habits.代谢功能障碍相关脂肪性肝病（MASLD）。评估代谢功能障碍、心血管危险因素和生活习惯。
Eur J Intern Med. 2025 Aug;138:101-111. doi: 10.1016/j.ejim.2025.05.018. Epub 2025 May 27.

引用本文的文献

1
Metabolic Dysfunction-associated Steatohepatitis and Cardiovascular Disease Prevention - Is Resmetirom Useful?代谢功能障碍相关脂肪性肝炎与心血管疾病预防——瑞美替昂有用吗？
Curr Vasc Pharmacol. 2025;23(1):4-7. doi: 10.2174/0115701611340703240809044916.